IPO Details
Bidding Dates
21 Jun 24 - 25 Jun 24
Price Range ₹
32 - 34
Total Equity
₹ 10.54Cr
Lot Size
4000
Exchange Status
NSE
IPO Doc
Subscription Rate
Non-Institutional Investor
0.00×
Qualified Institutional Buyers
0.00×
Employees
0.00×
Retail Investors
0.00×
Total subscription Rate
0.00×
IPO Timeline
Offer start
21 Jun 2024
Offer end
25 Jun 2024
Allotment
26 Jun 2024
Refund initiation
27 Jun 2024
Demat transfer
27 Jun 2024
Listing
28 Jun 2024
Offer start
21 Jun 2024
Offer end
25 Jun 2024
Allotment
26 Jun 2024
Refund initiation
27 Jun 2024
Demat transfer
27 Jun 2024
Listing
28 Jun 2024
About Company
Incorporated in 1995, Medicamen Organics Limited develops, manufactures, and distributes pharmaceutical dosages, including generic tablets, capsules, oral liquids, ointments, gels, syrups, suspensions, and dry powders. They serve both government (state and central) and private entities as a contract or third-party manufacturer. The company's product portfolio includes 84 items, offering a wide range of drugs such as antibacterials, antidiarrheals, antifungals, antimalarials, antidiabetics, proton pump inhibitors, antihistamines, antihypertensives, lipid preparations, antiparasitics, multivitamins, multiminerals, and non-steroidal anti-inflammatory drugs (NSAIDs). Medicamen Organics markets its products across India and internationally in countries like Congo, Benin, Kameg, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Burundi, Kyrgyzstan, and Kenya through third-party distributors. The company operates two WHO-GMP-approved manufacturing facilities in Haridwar, Uttarakhand, spanning 21,536 square feet. As of September 30, 2023, Medicamen Organics has entered into contract manufacturing agreements with 38 domestic partners and 12 merchant exporters.
Year Founded
15-03-1995
Promotor Details
Bal Kishan Gupta
Promoter Holdings Details
| Particular | Pre-IPO | Post-IPO |
|---|---|---|
| Percentage | 81.23 | 59.69 |
| Share Capital | 6983900 | 6983900 |
Offer to Public
31,00,000.00 Cr
Project Details
- Funding working capital requirements of our Company - 40cr
- Funding of expenses proposed to be incurred towards Product registration in the international market - 30cr
- Plant updation and increase in production capacity - 22.5cr
Objectives
- Funding of expenses proposed to be incurred towards Product registration in the international markets
- Plant updation and increase in production capacity
- Funding working capital requirements of our Company
- General Corporate Purposes.
Highlights
- Medicamen Organics holds ISO 9001:2015 certification for quality management systems.
- As of September 30, 2023, the company markets 84 products globally under various brand names.
- The company holds product manufacturing approvals in numerous international markets, including countries like Congo, the Philippines, and Kenya.
- Its manufacturing facilities in Ranipur, Haridwar, have "WHO" GMP approval.
- Medicamen Organics has a strong presence in India and overseas markets.
Challenges
- The company relies heavily on a few customers, with the top 10 customers accounting for a significant portion of total sales in recent years.
- A significant portion of the company's purchases comes from its top 10 suppliers, making it vulnerable to supplier-related disruptions.
- As of September 30, 2023, the company had outstanding secured loans worth Rs 5.84 crore, which could negatively impact its financial stability if not serviced properly.
- The company’s directors and promoters are involved in several legal proceedings, including 10 criminal cases and 15 tax-related cases, which could adversely affect the business if judgments are unfavorable.
- Any decline in product quality, increased competition, or shifts in demand could negatively impact the company’s business operations.
Financials
| Years | Total Assets | Share Capital | Profit After Tax | Consolidated Net Profit | Adjusted EPS |
|---|---|---|---|---|---|
| 2023 | 3,211.98 | 600.00 | 95.78 | 95.78 | 1.5963 |
| 2021 | 2,634.37 | 600.00 | 9.23 | 9.23 | 0.1538 |
| 2022 | 2,707.21 | 600.00 | 9.23 | 9.23 | 0.1538 |
